These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35047415)

  • 1. Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification.
    Bhat S; Pandey A; Kanakan A; Maurya R; Vasudevan JS; Devi P; Chattopadhyay P; Sharma S; Khyalappa RJ; Joshi MG; Pandey R
    Front Cell Infect Microbiol; 2021; 11():783961. PubMed ID: 35047415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
    Rego N; Costábile A; Paz M; Salazar C; Perbolianachis P; Spangenberg L; Ferrés I; Arce R; Fajardo A; Arleo M; Possi T; Reyes N; Bentancor MN; Lizasoain A; Benítez MJ; Bortagaray V; Moller A; Bello G; Arantes I; Brandes M; Smircich P; Chappos O; Duquía M; González B; Griffero L; Méndez M; Techera MP; Zanetti J; Rivera B; Maidana M; Alonso M; Alonso C; Medina J; Albornoz H; Colina R; Noya V; Iraola G; Fernández-Calero T; Moratorio G; Moreno P
    Emerg Infect Dis; 2021 Nov; 27(11):2957-2960. PubMed ID: 34437831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital.
    Schöning V; Liakoni E; Baumgartner C; Exadaktylos AK; Hautz WE; Atkinson A; Hammann F
    J Transl Med; 2021 Feb; 19(1):56. PubMed ID: 33546711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key.
    Maurya R; Mishra P; Swaminathan A; Ravi V; Saifi S; Kanakan A; Mehta P; Devi P; Praveen S; Budhiraja S; Tarai B; Sharma S; Khyalappa RJ; Joshi MG; Pandey R
    Front Cell Infect Microbiol; 2022; 12():868414. PubMed ID: 35386683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.
    Chatterjee S; Datey A; Sengupta S; Ghosh A; Jha A; Walia S; Singh S; Suranjika S; Bhattacharya G; Laha E; Keshry SS; Ray A; Pani SS; Suryawanshi AR; Dash R; Senapati S; Beuria TK; Syed GH; Prasad P; Raghav SK; Devadas S; Swain RK; Chattopadhyay S; Parida A
    Front Cell Infect Microbiol; 2021; 11():725035. PubMed ID: 34993157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
    Parums V.
    Med Sci Monit; 2021 Jun; 27():e933622. PubMed ID: 34149046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global landscape of SARS-CoV-2 genomic surveillance and data sharing.
    Chen Z; Azman AS; Chen X; Zou J; Tian Y; Sun R; Xu X; Wu Y; Lu W; Ge S; Zhao Z; Yang J; Leung DT; Domman DB; Yu H
    Nat Genet; 2022 Apr; 54(4):499-507. PubMed ID: 35347305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Shen Z; Xiao Y; Kang L; Ma W; Shi L; Zhang L; Zhou Z; Yang J; Zhong J; Yang D; Guo L; Zhang G; Li H; Xu Y; Chen M; Gao Z; Wang J; Ren L; Li M
    Clin Infect Dis; 2020 Jul; 71(15):713-720. PubMed ID: 32129843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA.
    Skidmore PT; Kaelin EA; Holland LA; Maqsood R; Wu LI; Mellor NJ; Blain JM; Harris V; LaBaer J; Murugan V; Lim ES
    Emerg Infect Dis; 2021 Oct; 27(10):2718-2720. PubMed ID: 34545803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms for predicting COVID outcome using ready-to-use laboratorial and clinical data.
    Lourenço AA; Amaral PHR; Paim AAO; Marques GF; Gomes-de-Pontes L; da Mata CPSM; da Fonseca FG; Pérez JCG; Coelho-Dos-Reis JGA
    Front Public Health; 2024; 12():1347334. PubMed ID: 38807995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern.
    Morris CP; Luo CH; Amadi A; Schwartz M; Gallagher N; Ray SC; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Apr; 74(8):1419-1428. PubMed ID: 34272947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
    Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
    Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.
    Chiara M; Horner DS; Gissi C; Pesole G
    Mol Biol Evol; 2021 May; 38(6):2547-2565. PubMed ID: 33605421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance.
    Rockett RJ; Draper J; Gall M; Sim EM; Arnott A; Agius JE; Johnson-Mackinnon J; Fong W; Martinez E; Drew AP; Lee C; Ngo C; Ramsperger M; Ginn AN; Wang Q; Fennell M; Ko D; Hueston L; Kairaitis L; Holmes EC; O'Sullivan MN; Chen SC; Kok J; Dwyer DE; Sintchenko V
    Nat Commun; 2022 May; 13(1):2745. PubMed ID: 35585202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.